November 14th 2019
Paris, November 14, 2019 – 6.00 pm CET
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced its participation in the Jefferies Healthcare Conference to be held on November 20-21, 2019 in London.
Stéphane Piat, Chief Executive Officer of CARMAT, will participate in investors meetings and present the company during a plenary session on Wednesday, November 20, at 5.20 pm (London time).
The presentation of CARMAT will be accessible live via the link: